Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Edouard M. Cantin is active.

Publication


Featured researches published by Edouard M. Cantin.


Journal of Virology | 2001

Gender Influences Herpes Simplex Virus Type 1 Infection in Normal and Gamma Interferon-Mutant Mice

Xiao Han; Patric Lundberg; Becky Tanamachi; Harry Openshaw; Jeff Longmate; Edouard M. Cantin

ABSTRACT Gender influences the incidence and severity of some bacterial and viral infections and autoimmune diseases in animal models and humans. To determine a gender-based difference, comparisons were made between male and female mice inoculated with herpes simplex virus type 1 (HSV-1) by the corneal route. Mortality was higher in the male mice of the three strains tested: 129/Sv//Ev wild type, gamma interferon (IFN-γ) knockout (GKO), and IFN-γ receptor knockout (RGKO). Similarly, in vivo HSV-1 reactivation occurred more commonly in male mice, but the male-female difference in reactivation was restricted to the two knockout strains and was not seen in the 129/Sv//Ev control. Comparison among male mice of the three strains showed a higher mortality of the RGKO mice and a higher reactivation rate of the GKO and RGKO mice than of the 129/Sv//Ev males. In contrast, female RGKO and GKO mice did not differ from female 129/Sv//Ev controls in either mortality or reactivation. HSV-1 periocular and eyelid disease was also more severe in male and dihydrotestosterone (DHT)-treated female mice than in control female mice. These results show a consistent gender difference in HSV-1 infection, with a worse outcome in male mice. In addition, the results comparing GKO and RGKO mice to controls show differences only in male mice, suggesting that some effects of IFN-γ, a key immunoregulatory molecule, are gender specific.


Current Eye Research | 1991

Detection of herpes simplex virus DNA sequences in corneal transplant recipients by polymerase chain reaction assays

Edouard M. Cantin; Jian Chen; James I. McNeill; Dru E. Willey; Harry Openshaw

Polymerase chain reaction (PCR) assays were used to amplify herpes simplex virus type 1 (HSV-1) thymidine kinase (TK) sequences in DNA extracted from formalin-fixed, paraffin embedded corneas of patients undergoing corneal transplantation. PCR reamplification with an internal (nested) set of primers was required for detection in 10 of the 12 positive corneas indicating very low abundance of viral sequences. Three of the positive corneal samples were from failed corneal grafts. Overall, TK sequences were detected in 8 of 11 corneas from subjects with a past history of herpes keratitis and in 4 of 11 corneas from subjects with no past history of herpetic eye disease.


Pharmacology & Therapeutics | 1991

The potential use of catalytic RNAs in therapy of HIV infection and other diseases

John J. Rossi; Edouard M. Cantin; Nava Sarver; Pairoj F. Chang

This article describes the applications (both real and potential) of a new antiviral strategy, based on the use of antisense, catalytic RNAs (ribozymes) as therapeutic agents. An understanding of both antisense inhibition of gene expression and RNA autocleavage reactions are essential to the use of this technology. In addition, for the successful application of this technology in clinical settings, an interdisciplinary approach involving clinicians, molecular and cellular biologists, will be necessary. The following treatise will highlight several salient features of ribozyme technology, emphasizing its application as an antiviral as well as discuss some problems and potential solutions pertinent to the clinical application of this technology.


Blood | 2015

Altered lymphopoiesis and immunodeficiency in miR-142 null mice.

Nicholas J. Kramer; Wei-Le Wang; Estefany Y. Reyes; Bijender Kumar; Ching-Cheng Chen; Chandran Ramakrishna; Edouard M. Cantin; Steven Vonderfecht; Konstantin D. Taganov; Nelson Chau; Mark P. Boldin

MicroRNAs (miRNAs) are a class of powerful posttranscriptional regulators implicated in the control of diverse biological processes, including regulation of hematopoiesis and the immune response. To define the biological functions of miR-142, which is preferentially and abundantly expressed in immune cells, we created a mouse line with a targeted deletion of this gene. Our analysis of miR-142(-/-) mice revealed a critical role for this miRNA in the development and homeostasis of lymphocytes. Marginal zone B cells expand in the knockout spleen, whereas the number of T and B1 B cells in the periphery is reduced. Abnormal development of hematopoietic lineages in miR-142(-/-) animals is accompanied by a profound immunodeficiency, manifested by hypoimmunoglobulinemia and failure to mount a productive immune response to soluble antigens and virus. miR-142(-/-) B cells express elevated levels of B-cell-activating factor (BAFF) receptor (BAFF-R) and as a result proliferate more robustly in response to BAFF stimulation. Lowering the BAFF-R gene dose in miR-142(-/-) mice rescues the B-cell expansion defect, suggesting that BAFF-R is a bona fide miR-142 target through which it controls B-cell homeostasis. Collectively, our results uncover miR-142 as an essential regulator of lymphopoiesis, and suggest that lesions in this miRNA gene may lead to primary immunodeficiency.


Current Eye Research | 2003

A potential role for CXCR3 chemokines in the response to ocular HSV infection.

Patric Lundberg; Edouard M. Cantin

Corneal infection with herpes simplex virus (HSV) leads to the recruitment of immune cells to the eye itself, the trigeminal ganglion and the brainstem. In addition, some resident cells in these target tissues are infected by HSV, activated during the inflammatory response or both. Chemokine signaling is an important component of the regulatory circuit governing the host immune response to virus infection. This review discusses chemokine responses in relation to HSV infection of the cornea emphasizing the role of CXCR3 chemokine signaling by the IFN-? inducible ligands MIG, IP10 and I-TAC and includes discussion of their potential role in immunopathology in the nervous system.


Intervirology | 1991

Application of Polymerase Chain Reaction Assays to Studies of Herpes simplex Virus Latency

Edouard M. Cantin; Winand Lange; Harry Openshaw

We have amplified herpes simplex virus type 1 (HSV-1) DNA sequences from individual latently infected mouse trigeminal ganglia by polymerase chain reaction (PCR) assays. This report presents two useful modifications in the PCR technique. The first involves the use of two sets of closely spaced, oppositely oriented oligonucleotide primers and two rounds of 20-40 PCR cycles, first with the more widely spaced outer primers and then with the internal nested primers. This method enhanced the sensitivity of PCR detection as shown by assays of HSV-1 sequences in human brain. The second modification was designed to detect selectively HSV-1 sense or anti-sense RNA transcripts when both are present by adding a single primer during an initial reverse-transcriptase-mediated cDNA synthesis reaction. After destruction of the RNA template, standard PCR is initiated by the addition of the second primer and thermus aquaticus DNA polymerase (Taq). We show here applications of both of these modifications to amplify HSV-1 sequences from nervous system tissue.


Journal of Controlled Release | 2012

Protection against TNFα-dependent liver toxicity by intraperitoneal liposome delivered DsiRNA targeting TNFα in vivo.

Patric Lundberg; Hui-Jung Yang; Seung-Jae Jung; Mark A. Behlke; Scott Rose; Edouard M. Cantin

Tumor necrosis factor-alpha (TNFα) is a classic proinflammatory cytokine implicated in the pathogenesis of several autoimmune and inflammatory diseases including viral encephalitis. Macrophages being major producers of TNFα are thus attractive targets for in vivo RNA interference (RNAi) mediated down regulation of TNFα. The application of RNAi technology to in vivo models however presents obstacles, including rapid degradation of RNA duplexes in plasma, insufficient delivery to the target cell population and toxicity associated with intravenous administration of synthetic RNAs and carrier compounds. We exploited the phagocytic ability of macrophages for delivery of Dicer-substrate small interfering RNAs (DsiRNAs) targeting TNFα (DsiTNFα) by intraperitoneal administration of lipid-DsiRNA complexes that were efficiently taken up by peritoneal macrophages and other phagocytic cells. We report that DsiTNFα-lipid complexes delivered intraperitoneally altered the disease outcome in an acute sepsis model. Down-regulation of TNFα in peritoneal CD11b+ monocytes reduced liver damage in C57BL/6 mice and significantly delayed acute mortality in mice treated with low dose LPS plus d-galactosamine (D-GalN).


Advances in Experimental Medicine and Biology | 1992

Antiviral effects of herpes simplex virus specific anti-sense nucleic acids.

Edouard M. Cantin; Gregory Podsakoff; Dru E. Willey; Harry Openshaw

We have targeted mRNA sequences encompassing the translation initiation codon of the essential herpes simplex virus type 1 (HSV-1) IE3 gene with three kinds of anti-sense molecule. Addition of a 15mer oligodeoxyribonucleoside methylphosphonate to tissue culture cells resulted in suppression of viral replication. HSV-1 replication was also inhibited in cultured cells containing anti-sense vectors expressing transcripts complementary to the IE3 mRNA. We have also constructed a ribozyme which upon base pairing with the target IE3 mRNA induces cleavage at the predicted GUC site. A major obstacle to anti-sense studies in animals is drug delivery of preformed antisense molecules to ganglionic neurons, the site of HSV latency and reactivation. We speculate as to how this may be accomplished through carrier compounds which are taken up by nerve terminals and transported by retrograde axoplasmic flow. By the same route, HSV itself may be used as an anti-sense vector.


Archives of Virology | 1997

Genetic and functional complementation of the HSV1 UL27 gene and gB glycoprotein by simian α-herpesvirus homologs

R. Eberle; B. Tanamachi; Darla H. Black; E. L. Blewett; M. Ali; Harry Openshaw; Edouard M. Cantin

SummaryUtilizing co-transfection of DNA from glycoprotein gB− strain of HSV1 and cloned fragments of several simian α-herpesviruses containing the UL26, UL27 (gB glycoprotein), and UL28 gene homologs, replication-compe-tent recombinant viruses were produced. Genetic analysis of one HSVI/SAff8 recombinant (HSV1/SgB) demonstrated the presence of SAff8 DNA comprising the entire UL27 (gB) gene and parts of the UL28 and UL26 ORFs in an otherwise HSV1 genome. The recombinant was shown to express the SAff8 gB and p40 proteins (UL27 & UL26.5 gene products, respectively); all other proteins were indistinguishable from those of HSV1. The recombinant behaved like SAff8 in gB-specific virus neutralization and cell surface antibody binding assays, while plaque morphology and replication kinetics were very similar to HSV1. Despite its overwhelming HSV1 genetic constitution, the recombinant displayed a pathogenic phenotype in mice very different from the parental HSV1. While HSV1 produced corneal disease in ocularly infected mice and readily spread to the nervous system, HSV1/SgB was markedly impaired in both respects. These results demonstrate the functional equivalency of the cercopithecine monkey virus gB glycoproteins and genes (including transcriptional regulatory elements) in HSV1, the funtional nature of HSV1/SAff8 chimeric UL28 and UL26 genes/proteins, and that UL28, gB and/or p40 proteins may effect the pathogenicity of HSV1.


Trends in Microbiology | 1993

Antisense oligonucleotides as antiviral agents: prospects and problems

Edouard M. Cantin; Tod M. Woolf

One possible strategy for the development of antiviral drugs is to synthesize short antisense oligonucleotides that interfere specifically with RNA transcription and processing to prevent expression of protein. This can be readily achieved, but there are formidable technical problems to solve before routine clinical applications can be envisaged.

Collaboration


Dive into the Edouard M. Cantin's collaboration.

Top Co-Authors

Avatar

Harry Openshaw

City of Hope National Medical Center

View shared research outputs
Top Co-Authors

Avatar

Patric Lundberg

Eastern Virginia Medical School

View shared research outputs
Top Co-Authors

Avatar

John J. Rossi

City of Hope National Medical Center

View shared research outputs
Top Co-Authors

Avatar

John A. Zaia

City of Hope National Medical Center

View shared research outputs
Top Co-Authors

Avatar

Dru E. Willey

City of Hope National Medical Center

View shared research outputs
Top Co-Authors

Avatar

Nava Sarver

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Pairoj S. Chang

Beckman Research Institute

View shared research outputs
Top Co-Authors

Avatar

Chandran Ramakrishna

City of Hope National Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jian Chen

City of Hope National Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge